Pancreatic Cancer Research

ResearcherShanghai Jiao Tong UniversityActive in the last 2 years

Wenguo Cui

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0002-6938-9582; OpenAlex author ID A5085065266. Sources: OpenAlex.

Their work

Papers
2 (first author 0, last author 1)
Trials
0
Grants
0
Labs led
0
Collaborators
9
Papers, trials and grants by year

2018: 1 paper · 2019: none · 2020: none · 2021: none · 2022: none · 2023: none · 2024: none · 2025: 1 paper

Papers 2

  1. Irreversible electroporation combined with PD-L1/IL-6 dual blockade promotes anti-tumor immunity via cDC2/CD4+T cell axis in MHC-I deficient pancreatic cancer. Co-author DOI 10.1016/j.canlet.2025.217620↗
  2. Localized Controlled Delivery of Gemcitabine via Microsol Electrospun Fibers to Prevent Pancreatic Cancer Recurrence. Last author DOI 10.1002/adhm.201800593↗

Closest collaborators

The 9 strongest of 9 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Xiaoyu Liu · 1 shared paper, 2025 · strength 0.21
  2. Zhongmin Wang · 1 shared paper, 2025 · strength 0.21
  3. Zhuozhuo Wu · 1 shared paper, 2025 · strength 0.21
  4. Chenlei Wen · 1 shared paper, 2025 · strength 0.21
  5. Guanggai Xia · 1 shared paper, 2018 · strength 0.08
  6. Hongcheng Wang · 1 shared paper, 2018 · strength 0.08
  7. Hélder A. Santos · 1 shared paper, 2018 · strength 0.08
  8. Hongbo Zhang · 1 shared paper, 2018 · strength 0.08
  9. Xinyu Huang · 1 shared paper, 2018 · strength 0.08

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.